Advertisement

Regulation and Deregulation of HLA Class II Genes

  • B. Mach
  • W. Reith

Abstract

The role of MHC class II molecules in the presentation of antigens to the receptors of T lymphocytes is well documented. A key feature of MHC class II molecules is their extensive allelic polymorphism. The effect of this structural diversity on the presentation of antigens and on restricted recognition by T cells has been extensively studied at the molecular level (Schwartz 1985). Less attention has been given, however, to the effect of quantitative variations in the level of MHC class II gene expression on the activation of T lymphocytes and on the control of the immune response (Matis et al. 1983). Yet it is evident that such quantitative variations must have important functional consequences in both normal and pathological immune responses as well as for the development of tolerance and the generation of the T cell repertoire by selection events occurring in the thymus. The extent of T cell activation has been shown to be dependent on both the concentration of antigen and the cell surface density of MHC class II molecules (Matis et al. 1983). It has also been proposed that positive selection of specific T cell clones in the thymus depends on the density of MHC class II molecules on thymic epithelial cells (Berg et al. 1990). Finally, the aberrant activation of autoreactive T cells observed in autoimmune diseases has been attributed to abnormal expression of class II molecules in specific cell types. From these considerations, it follows that a better understanding of the molecular mechanisms implicated in the fine control of MHC class II gene expression represents an essential objective.

Keywords

Major Histocompatibility Complex Major Histocompatibility Complex Class Cell Surface Density Octamer Binding Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Accolla RS (1983) Human B cell variants immunoselected against a single la antigen subset have lost expression in several la antigen subsets. J Exp Med 157:1053–1057PubMedCrossRefGoogle Scholar
  2. Basta PV, Sherman PA, Ting JP (1988) Detailed delineation of an interferon-gamma-responsive element important in human HLA-DRA gene expression in a glioblastoma multiform line. Proc Natl Acad Sci USA 85:8618–8622PubMedCrossRefGoogle Scholar
  3. Benoist C, Mathis D (1990) Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet. Annu Rev Immunol 8:681–715PubMedCrossRefGoogle Scholar
  4. Berg LJ, Frank GD, Davis MM (1990) The effect of MHC gene dosage and allelic variation on T cell receptor selection. Cell 60:1043–1053PubMedCrossRefGoogle Scholar
  5. Caiman AF, Peterlin BM (1987) Mutant human B cell lines deficient in class II major histocompatibility complex transcription. J Immunol 139:2489–2495Google Scholar
  6. Dedrick RL, Jones PP (1990) Sequence elements required for activity of a murine major histocompatibility complex class II promoter bind common and cell-type-specific nuclear factors. Mol Cell Biol 10:593–604Google Scholar
  7. Depreval C, Griscelli C, Mach B, Loche M, Lisowska-Grospierre B (1985) A trans-acting class-II regulatory gene unlinked to the MHC controls expression of HLA class-II genes. Nature 318:291–293CrossRefGoogle Scholar
  8. Depreval C, Hadam MR, Mach B (1988) Regulation of genes for HLA class-II antigens in cell-lines from patients with severe combined immunodeficiency. Engl J Med 318:1295–1300CrossRefGoogle Scholar
  9. Diedrichs M, Schendel DJ (1989) Differential surface expression of class-II isotypes on activated CD 4 and CD 8 cells correlates with level of locus-specific messenger-RNA. J Immunol 142:3275–3280PubMedGoogle Scholar
  10. Dorn A, Durand B, Marfing C, Le Meur M, Benoist C, Mathis D (1987) Conserved major histocompatibility complex class II boxes — X and Y — are transcriptional control elements and specifically bind nuclear proteins. Proc Natl Acad Sci USA 84:6249–6253PubMedCrossRefGoogle Scholar
  11. Dorn A, Fehling HJ, Koch W, Le Meur M, Gerlinger P, Benoist C, Mathis D (1988) B-cell control region at the 5’ end of a major histocompatibility complex class II gene: sequences and factors. Mol Cell Biol 8:3975–3987PubMedGoogle Scholar
  12. Gönzky P, Reith W, Barras E, Hadam MR, Lisowska-Grospierre B, Griscelli C, Mach B (1989) Inherited immunodeficiency with a transregulatory defect in MHC class II gene expression differs in the chromatin structure of the HLA DRA gene. Mol Cell Biol 9:296–301Google Scholar
  13. Griscelli C, Lisowska-Grospierre B, Mach B (1989) Combined immunodeficiency with defective expression in MHC class II genes. Immunodefic Rev 1:135–153PubMedGoogle Scholar
  14. Kara CJ, Glimcher LH (1991) Regulation of MHC class II gene transcription. Curr Opin Immunol 3:16–21PubMedCrossRefGoogle Scholar
  15. Kara CJ, Liou H-C, Ivashkiv LB, Glimcher LH (1990) A cDNA for a human cyclic AMP response element-binding protein which is distinct from CREB and expressed preferentially in brain. Mol Cell Biol 10:1347–1357PubMedGoogle Scholar
  16. Kobr M, Reith W, Herrero Sanchez C, Mach B (1990) Two DNA-binding proteins discriminate between the promoters of different members of the major histocompatibility complex class II multigene family. Mol Cell Biol 10:965–971PubMedGoogle Scholar
  17. Koch W, Candeias S, Guardiola J, Accolla R, Benoist C, Mathis D (1988) An enhancer defect in a mutant Burkitt lymphoma cell line. J Exp Med 167:1781–1790PubMedCrossRefGoogle Scholar
  18. Koch W, Benoist C, Mathis D (1989) Anatomy of a new B-cell-specific enhancer. Mol Cell Biol 9:303–311PubMedGoogle Scholar
  19. Liou HC, Boothby MR, Glimcher LH (1988) Distinct cloned class II MHC DNA binding proteins recognize the X box transcription element. Science 242:69–71PubMedCrossRefGoogle Scholar
  20. Liou HC, Boothby MR, Finn PW, Davidon R, Nabavi N, Zeleznikle NJ, Ting JPY, Glimcher LH (1990) A new member of the leucine zipper class of proteins that binds to the HLA Dr-alpha promoter. Science 247:1581–1584PubMedCrossRefGoogle Scholar
  21. Mach B, Berte C, Tiercy JM, Reith W (1990) Diversity and regulation of MHC class II genes. In: Silver J (ed) Molecular biology of HLA class II antigens. CRC, Boca Banton, pp 201–223Google Scholar
  22. Mathis DJ, Benoist CO, Williams VE, Kanter MR, McDevitt HO (1983) The murine E alpha immune response gene. Cell 32:745–754PubMedCrossRefGoogle Scholar
  23. Matis LA, Glimcher LH, Paul WE, Schwarz RH (1983) Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and la molecules. Proc Natl Acad Sci USA 80:6019–6023PubMedCrossRefGoogle Scholar
  24. Miwa K, Doyle C, Strominger JL (1987) Sequence specific interaction of nuclear factors with conserved sequences of human class II major histocompatibility complex genes. Proc Natl Acad Sci USA 84:4939–4943PubMedCrossRefGoogle Scholar
  25. Okada K, Prentice HL, Boss JM, Levy DJ, Kappes D, Spies T, Raghupathy R, Mengler RA, Auffray C, Strominger JL (1985) SB subregion of the human major histocompatibility complex: gene organization allelic polymorphism and expression in transformed cells. EMBO J 4:739–748PubMedGoogle Scholar
  26. Reith W, Satola S, Sanchez CH, Amaldi I, Lisowska-Grospierre B, Griscelli C, Hadam MR, Mach B (1988) Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X. Cell 53:897–906PubMedCrossRefGoogle Scholar
  27. Reith W, Reinhart D, Sanchez CH, Satola S, Barras E, Mach B, Kobr M (1989) Cloning of the major histocompatibility complex class-II promoter binding-protein affected in a hereditary defect in class-II gene-regulation. Proc Natl Acad Sci USA 86:4200–4204PubMedCrossRefGoogle Scholar
  28. Reith W, Herrero Sanchez C, Kobr M, Silacci P, Berte C, Barras E, Fey S, Mach B (1990) MHC class II regulatory factor RF-X has a novel DNA-binding domain and a functionally independent dimerization domain. Genes Dev 4:1528–1540PubMedCrossRefGoogle Scholar
  29. Sakurai M, Strominger JL (1988) B-cell-specific enhancer activity of conserved upstream elements of the class II major histocompatibility complex DQB gene. Proc Natl Acad Sci USA 85:6909–6913PubMedCrossRefGoogle Scholar
  30. Schwartz R (1985) T-lymphocyte recognition of antigen in association with the gene products of the major histocompatibility complex. Annu Rev Immunol 3:237PubMedCrossRefGoogle Scholar
  31. Sherman PA, Basta PV, Ting JPY (1987) Upstream DNA sequences required for tissue-specific expression of the HLA-DRA gene. Proc Natl Acad Sci USA 84:4254–4258PubMedCrossRefGoogle Scholar
  32. Sherman PA, Basta PV, Heguy A, Wloch MK, Roeder RG, Ting JP-Y (1989) The octamer motif is a B-lymphocyte-specific regulatory element of the HLA-DR-alpha gene promoter. Proc Natl Acad Sci USA 86:6739–6743PubMedCrossRefGoogle Scholar
  33. Tsang SY, Nakanishi M, Peterlin BM (1988) B-cell-specific and interferon-gamma-inducible regulation of the HLA-DR alpha gene. Proc Natl Acad Sci USA 85:8598–8602PubMedCrossRefGoogle Scholar
  34. Tsang SY, Nakanishi M, Peterlin BM (1990) Mutational analysis of the DRA promoter: cis-acting sequences and trans-acting factors. Mol Cell Biol 10:711–719PubMedGoogle Scholar
  35. Wraith DC, McDevitt HO, Steinman L, Acha-Orbea H (1989) T cell recognition as the target for immune intervention in autoimmune disease. Cell 57:709–715PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • B. Mach
  • W. Reith

There are no affiliations available

Personalised recommendations